Zydus Cadila, the drug firm has got the US health regulator’s approval for marketing Mirtazapine orally disintegrating tablets, an anti depressant, in the American market.

The company has said in a BSE filing that Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market the Mirtazapine orally disintegrating tablets USP in strengths 15mg, 30mg and 45mg.

The company is going to manufacture the product at its facility in Baddi.

Read EquityPandit’s Nifty Pharma Outlook for this week